Weight-loss drug ‘flying off the shelves’ kicks Denmark’s GDP up a gear

The explosive success of Novo Nordisk’s weight-loss drug Wegovy has sent Denmark’s GDP skyward. But the national economy is less rosy without big pharma in the equation.

The explosive success of Novo Nordisk’s weight-loss drug Wegovy has sent Denmark’s GDP skyward. But the national economy is less rosy without big pharma in the equation.


Gain unlimited access to all of The Copenhagen Post

Our independent reporting can only be published with support from our readers.

Monthly subscription

119

DKK/month.

(Billed once a month)

Give us a try

6 month subscription

99

DKK/month.

(Billed twice a year)

Save 120 DKK

Yearly subscription

79

DKK/month.

(Billed once a year)

Save 480 DKK

Save with a company subscription?




Connect Club is your gateway to a vibrant programme of events and an international community in Denmark.